Hypergastrinaemia
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trio MedicinesUK - London
3 programsYF476PHASE_11 trial
YF476PHASE_11 trial
YF476PHASE_11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Trio MedicinesYF476
Trio MedicinesYF476
Trio MedicinesYF476
Clinical Trials (3)
Total enrollment: 54 patients across 3 trials
Effects of YF476 and Rabeprazole on Gastric Function
Start: Aug 2006Est. completion: Jun 200732 patients
Phase 1Completed
Effect of Repeated Doses of YF476 on Stomach Acidity
Start: Oct 2001Est. completion: Nov 200110 patients
Phase 1Completed
Effect of Single Doses of YF476 on Stomach Acidity
Start: Oct 2001Est. completion: Jan 200212 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.